19 Novembre 2026

Psicologia Punto One | Psicologia e Psicologi nel Web

Menu

Menu

SCHEDA SCIENTIFICA2026Altra ricerca

Thirteen-month real-world effectiveness and safety of lecanemab in Chinese patients with Alzheimer's disease: integrating objective clinical outcomes and caregiver-reported experiences.

Sihui Chen, Xinyao Gao, Fanglan Li, Ruwei Ou, Qianqian Wei, Chunyu Li, Wei Song, Bi Zhao, Jing Yang, Jiajia Fu, Yuanzheng Ma, Xiangming Wang, Dengfu Fang, Tao Hu, Li Xiao, Shushan Zhang, Rui Huang, Xiaoyan Guo, Fei Feng, Xueping Chen, Huifang Shang, Alzheimer’s Disease Neuroimaging Initiative

Journal of neurology · 2026

Abstract e pubblicazione originale

L’abstract è consultabile nella fonte originale. Non viene ripubblicato qui perché non risulta verificata una licenza compatibile.

Leggi nella fonte originale ↗

Parole chiave

HumansAlzheimer DiseaseFemaleMaleAgedCaregiversTreatment OutcomeProspective StudiesAged, 80 and overChinaPositron Emission Tomography Computed TomographyAmyloid beta-PeptidesMiddle AgedFollow-Up StudiesCognitive DysfunctionEast Asian PeopleAlzheimer’s diseaseAmyloid clearanceCognitive trajectoryLecanemabReal-world evidence

Come citare questo studio

Sihui Chen, Xinyao Gao, Fanglan Li, Ruwei Ou, Qianqian Wei, Chunyu Li, Wei Song, Bi Zhao, Jing Yang, Jiajia Fu, Yuanzheng Ma, Xiangming Wang, Dengfu Fang, Tao Hu, Li Xiao, Shushan Zhang, Rui Huang, Xiaoyan Guo, Fei Feng, Xueping Chen, Huifang Shang, Alzheimer’s Disease Neuroimaging Initiative. (2026). Thirteen-month real-world effectiveness and safety of lecanemab in Chinese patients with Alzheimer's disease: integrating objective clinical outcomes and caregiver-reported experiences.. Journal of neurology. DOI: 10.1007/s00415-026-14270-6

Consulta la pubblicazione originale ↗